mr. Harm de Vries
Harm has extensive experience in structuring, establishing, monitoring and exiting technology companies and university spin-outs and in setting-up and operating (university) venture funds. Harm co-founded the Twente Technology Fund in 2010.
In 2007 Harm had also co-founded the Erasmus MC Biomedical Fund and in 2009 the Life Sciences Fund Amsterdam. Harm holds board positions at several technology companies. Previously, Harm worked as General Counsel at LSP, where he was responsible for structuring and negotiating investments and divestments (M&A, IPO) of the portfolio companies, including legal due diligence, drafting of term sheets and contracts, and review of intellectual property.
Harm started his career as an attorney in law at an Amsterdam-based international law firm. Harm has acted as speaker at many venture capital related symposia and was amongst others speaker at EVCA Venture Capital Courses for Investment Professionals. In 2005, Harm authored the guidebook: “Venture Capital Term Sheets, a guide to structuring and negotiating venture capital term sheets” (Reed Elsevier).